TGFB1 and urinary bladder carcinoma: To summarize, our study demonstrated that AHSG promotes the proliferation of bladder cancer cells by regulating the TGF-β signaling pathway, thereby promoting bladder cancer progression, suggesting that AHSG may be a potential target for clinical diagnosis and treatment of bladder cancer.